Positive effect of CPAP therapy in OSA patients on A-FABP, CRP and triacylglycerols levels and diastolic blood pressure

M. Hobzova, E. Sovova, D. Stejskal, V. Kolek, J. Zapletalova, M. Sova (Prostejov, Czech Republic)

Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Session: Metabolic and cardiovascular consequences of OSA I
Session type: Thematic Poster Session
Number: 3804
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Hobzova, E. Sovova, D. Stejskal, V. Kolek, J. Zapletalova, M. Sova (Prostejov, Czech Republic). Positive effect of CPAP therapy in OSA patients on A-FABP, CRP and triacylglycerols levels and diastolic blood pressure. Eur Respir J 2012; 40: Suppl. 56, 3804

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in patients with OSAS with emphasis on gender differences
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011

No reduction of blood pressure with CPAP in non-sleepy hypertensive OSA patients
Source: ISSN=ISSN 1810-6838, ISBN=, page=193
Year: 2006

Elevated serum erythropoietin level in obesity hypoventilation syndrome patients improved by nasal positive pressure ventilation therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 101s
Year: 2002

The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005


Blood pressure response to CPAP treatment in subjects with obstructive sleep apnoea: the predictive value of 24-h ambulatory blood pressure monitoring
Source: Eur Respir J, 50 (4) 1700651; 10.1183/13993003.00651-2017
Year: 2017



Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018

Effect of continuous positive airway pressure on 24 h ambulatory blood pressure in hypertensive patients with OSA
Source: Eur Respir J 2007; 30: Suppl. 51, 333s
Year: 2007

Resting electrocardiographic (EKG) changes, the cardiovascular risk factors and the effect of CPAP (continuous positive airways pressure) therapy on high blood pressure evolution in patients with sleep apnoea syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 564s
Year: 2005

Positive effect of CPAP treatment on the control of difficult-to-treat hypertension
Source: Eur Respir J 2007; 29: 951-957
Year: 2007



The relationship between serum MMP-9 concentration and arterial blood oxygenation in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 20s
Year: 2007

Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea
Source: Eur Respir J, 50 (2) 1700257; 10.1183/13993003.00257-2017
Year: 2017



Positive airway pressure treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients: Longitudinal data from the ESADA
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Long term effects of CPAP in blood pressure in nonsleepy hypertensive OSA patients
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008

Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005

Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients
Source: Eur Respir J 2006; 27: 1229-1235
Year: 2006



Morning microalbuminuria, as a prognostic factor to predict blood pressure increase in patients with sleep aponea syndrome
Source: Eur Respir J 2003; 22: Suppl. 45, 90s
Year: 2003

Weight changes and CPAP pressure in obesity patients with SAHS
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008

Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Effect of 3-month CPAP treatment on blood pressure and serum aldosterone concentration in patients with resistant hypertension
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013